Rezvoglar Kwikpen

Generic name:insulin glargine-aglr
Dosage form: injection, solution
Drug class:Insulin

Medically reviewed by Drugs.com. Last updated on Dec 1, 2021.

Indications and Usage for Rezvoglar Kwikpen

REZVOGLAR™ is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Limitations of Use

REZVOGLAR is not recommended for the treatment of diabetic ketoacidosis.

Rezvoglar Kwikpen Dosage and Administration

Important Administration Instructions

• Administer REZVOGLAR subcutaneously once daily at any time of day but at the same time every day.
• Prior to initiation of REZVOGLAR, train patients on proper use and injection technique.
• Patient should follow the Instructions for Use to correctly administer REZVOGLAR.
• Administer REZVOGLAR subcutaneously into the abdominal area, thigh, or deltoid, and rotate injection sites within the same region from one injection to the next to reduce the risk of lipodystrophy and localized cutaneous amyloidosis. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Precautions (5.2), Adverse Reactions (6)].
• During changes to a patient's insulin regimen, increase the frequency of blood glucose monitoring [see Warnings and Precautions (5.2)].
• Visually inspect Rezvoglar Kwikpen prefilled pens for particulate matter and discoloration prior to administration. Only use if the solution is clear and colorless with no visible particles.
• The Rezvoglar Kwikpen prefilled pen dials in 1-unit increments.
• Use Rezvoglar Kwikpen prefilled pen with caution in patients with visual impairment who may rely on audible clicks to dial their dose.
• Refrigerate unused (unopened) Rezvoglar Kwikpen prefilled pens.
• Do not administer intravenously or via an insulin pump.
• Do not dilute or mix REZVOGLAR with any oth...